Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "COPD Exacerbations"
A special issue of Medical Sciences (ISSN 2076-3271). This special issue belongs to the section "Pneumology and Respiratory Diseases".
Deadline for manuscript submissions: closed (31 March 2018) | Viewed by 30513
Special Issue Editors
Interests: Pulmonary medicine; COPD; pneumonia
Interests: respiratory medicine; epidemiology; risk factors; outcome; treatment; prevention and pathogenetic mechanisms of respiratory infections; community-acquired pneumonia; intensive care
Special Issues, Collections and Topics in MDPI journals
Special Issue in Medical Sciences: Idiopathic Pulmonary Fibrosis
Special Issue in Journal of Clinical Medicine: Diagnosis and Treatment of Pneumonia
Special Issue in Medical Sciences: Feature Papers in Medical Sciences
Special Issue in Biomedicines: Pneumonia Basic Science
Special Issue in Medical Sciences: Pneumonia Basic Science
Special Issue in Medical Sciences: 10th Anniversary of Medical Sciences — Advances in Basic, Translational and Clinical Research
Special Issue Information
Chronic obstructive pulmonary disease (COPD) is the most common respiratory comorbidity in the world, and has a significant impact on morbidity and mortality. Exacerbations of COPD (AECOPD)—pneumonic and non-pneumonic—are important events in the natural history of a disease, because the number of episodes of hospitalization and costs associated with COPD are associated with these clinical events. These exacerbations involve predominately neutrophilic inflammation in response to aggression by external microorganisms, pollution and sometimes of unknown cause.
In recent years, literature has focused on the different phenotypes of exacerbation (including the Asthma–COPD overlap), the impact of other causal agents of AECOPD, such as fungi, the role of eosinophils (in stable and during exacerbations) and the impact of new inhaled molecules in the prevention of these events. There is also a concern on new therapies such as macrolides to prevent exacerbations, the role of microbiome and new evidence on the use of non-invasive ventilation and emerging multidrug-resistant microorganisms as etiologic agents.
In this Special Issue of Medical Sciences we will cover the latest evidence not only on the diagnosis, but also the novelties on therapeutics from top experts in the field.
Dr. Arturo Huerta
Prof. Antoni Torres
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medical Sciences is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Chronic obstructive pulmonary disease (COPD)